Abstract:What is known and Objective: Cytochrome P450 2C19 (CYP2C19) and CYP2D6 are important xenobiotic metabolic enzymes and both show considerable genetic variability between Orientals and Caucasians. There are known marked heterogeneity in susceptibility to various cancers and hypertension among Chinese Mongolian, Hui and Han ethnic groups, but the molecular mechanisms are unknown. Our objective was to investigate the patterns of distribution of CYP2C19 and CYP2D6 polymorphisms among healthy Chinese subjects to determine whether any observed inter-ethnic variability might be worth further investigation as possible contributors to the known differences in disease prevalence. Methods: Blood samples were collected from 454 unrelated Chinese healthy subjects (214 Han, 111 Hui, 129 Mongolian) for genotyping analysis. The single nucleotide polymorphisms (SNPs) CYP2C19*2 (681G>A in exon 5), CYP2C19*3 (636G>A in exon 4) and CYP2D6*10 (188C>T in exon 1) were determined by the polymerase chain reactionrestriction fragment length polymorphism (PCR-RFLP) method. Results and Discussion: Significantly higher frequencies of the CYP2C19 poor metabolic genotypes were observed in Chinese Han (18.7%), Chinese Hui (25.0%) and Chinese Mongolian (10.9%) subjects than has been reported for Caucasians (1.73.0%, P < 0.01). The prevalent defective allele CYP2C19*2 occurred more frequently in both Chinese Hui (32.4%) and Han (29.7%) than in Chinese Mongolian (18.2%, P < 0.01) subjects. The CYP2C19*2 and CYP2C19*3 defective alleles were significantly more frequent in Chinese Han and Chinese Hui ethnic groups than have been reported for Caucasians (11.116.3% and 00.2%, P < 0.01). CYP2D6*1/*10 heterozygotes and CYP2D6*10/*10 homozygotes were observed more frequently in Chinese Han (43.1% and 27.2%), Hui (40.6% and 30.7%) and Mongolian subjects (31.3% and 9.6%, both P < 0.01) than have been reported for Caucasians (5.5% and 0.3%, P < 0.01). In Chinese Mongolians, the CYP2D6*10 allele occurred at a frequency (25.2%, P < 0.01) intermediate between those reported for Caucasians and the other two Chinese ethnic populations. What is new and Conclusions: This is first report of interethnic differences in frequencies of functional CYP2C19 and CYP2D6 genes among Chinese Mongolian, Hui and Han populations. These differences may be important in explaining reported inter-ethnic differences in disease prevalence and response to drugs.

Influence of CYP3A5 and MDR1 Genetic Polymorphisms on Urinary 6β‐hydroxycortisol/cortisol Ratio after Grapefruit Juice Intake in Healthy Chinese

Identification and Functional Assessment of EightCYP3A4Allelic Variants39–46Detected in the Chinese Han Population

Genetic Polymorphisms in Mdr1 and Cyp3a5 and Mdr1 Haplotype in Mainland Chinese Han, Uygur and Kazakh Ethnic Groups

Cyp3a5*3 and Mdr-1 C3435t Single Nucleotide Polymorphisms in Six Chinese Ethnic Groups

CYP3A53 and CYP3A418 Single Nucleotide Polymorphisms in a Chinese Population.

MDR1 Gene Polymorphisms Are Associatedwith Glucocorticoid-Induced Avascular Necrosisof the Femoral Head in a Chinese Population

The G-113a Polymorphism In Cyp1a2 Affects The Caffeine Metabolic Ratio In A Chinese Population

Genetic Polymorphisms of the Drug-Metabolizing Enzyme Cytochrome P450 3a5 in A Uyghur Chinese Population

Genotyping study of CYP3A5 in Healthy Han,Uygur and Kazakh Chinese

Frequencies of Genotypes and Alleles of the Functional SNPs in CYP2C19 and CYP2E1 in Mainland Chinese Kazakh, Uygur and Han Populations

Effect of Glycyrrhizin on CYP2C19 and CYP3A4 Activity in Healthy Volunteers with Different CYP2C19 Genotypes

Influence of CYP3A5 Genetic Polymorphism on Cyclosporine A Metabolism and Elimination in Chinese Renal Transplant Recipients

Effect of CYP3A5 and MDR1 Gene Polymorphism on Concentration/Dose Ratios of Tacrolimus in Chinese Liver Transplant Patients

Polymorphisms and Phenotypic Analysis of Cytochrome P450 3A4 in the Uygur Population in Northwest China.

Intra-ethnic Differences in Genetic Variants of the UGT-glucuronosyltransferase 1A1 Gene in Chinese Populations

Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics and pharmacodynamics of gliclazide in healthy Chinese Han volunteers: Influenceof CYP2C9 and CYP2C19 genetic polymorphisms

Genetic polymorphism analysis of the drug-metabolizing enzyme CYP1A2 in a Uyghur Chinese population: a pilot study.

Allele C of rs6068816 in the CYP24A1 Gene is Associated with Increased Risk of Hyperuricemia in the Chinese Population: A Case-Control Study

Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics of gliclazide MR in Chinese subjects.

Differences in Genotype and Allele Frequency Distributions of Polymorphic Drug Metabolizing Enzymes CYP2C19 and CYP2D6 in Mainland Chinese Mongolian, Hui and Han Populations

Allele and Genotype Frequencies of CYP3A4, CYP3A5, CYP3A7, and GSTP1 Gene Polymorphisms among Mainland Tibetan, Mongolian, Uyghur, and Han Chinese Populations.